Healthcare

Dems demand ethics probe into Price’s stock trades

By Susan Crabtree
Published January 5, 2017 2:50pm ET
Add Washington Examiner on Google
Dems demand ethics probe into Price’s stock trades
Rep. Tom Price, R-Ga., traded more than $300,000 in shares of health-related companies during the past four years, the Wall Street Journal reported in late December. Over that same period, Price authored or co-authored dozens of related bills in the House during this time that Democrats argue could affect the same companies' stock prices. (AP Photo/J. Scott Applewhite) | J. Scott Applewhite

Senate Minority Leader Chuck Schumer and several other key Democrats are demanding a new ethics investigation into the personal finances of Rep. Tom Price, R-Ga., President-elect Trump’s choice to lead the effort to overhaul Obamacare.

The Democrats argue that the investigation, which could take months to complete, must take place and produce its findings before the Senate holds hearings on Price’s nomination to become Health and Human Services Secretary.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Congress Department of Health and Human Services Ethics Minusextra Susan Crabtree Tom Price Wall Street Watchdog